Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Naviscan PET Systems Inc.

Latest From Naviscan PET Systems Inc.

Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover recent device M&A, Medtronic and Nile Therapeutics' collaboration in heart failure, Neoprobe and Naviscan PET Systems' deal in cancer detection, and Qiagen and Epigenomics AG's collaboration in a blood test for colorectal cancer.
Medical Device

Deals Update (05/2007)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Naviscan PET Systems Inc.
  • Senior Management
  • Paul J Mirabella, Pres. & CEO
    Kathleen Winer, CFO
    Sherri Antoniak, VP, Corp. Dev.
    Sharon Smith, VP, Sales & Mktg.
  • Contact Info
  • Naviscan PET Systems Inc.
    Phone: (858) 587-3641
    11180 Roselle St.
    Ste. 100
    San Diego, CA 92121